Lexeo Therapeutics Statistics

Total Valuation

LXEO has a market cap or net worth of $372.98 million. The enterprise value is $187.30 million.

Market Cap	372.98M
Enterprise Value	187.30M

Important Dates

The next estimated earnings date is Thursday, August 13, 2026, before market open.

Earnings Date	Aug 13, 2026
Ex-Dividend Date	n/a

Share Statistics

LXEO has 78.52 million shares outstanding. The number of shares has increased by 98.55% in one year.

Current Share Class	78.52M
Shares Outstanding	78.52M
Shares Change (YoY)	+98.55%
Shares Change (QoQ)	+6.32%
Owned by Insiders (%)	0.26%
Owned by Institutions (%)	76.31%
Float	47.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.52
P/TBV Ratio	1.61
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 14.16, with a Debt / Equity ratio of 0.03.

Current Ratio	14.16
Quick Ratio	13.61
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,164.11

Financial Efficiency

Return on equity (ROE) is -54.75% and return on invested capital (ROIC) is -36.34%.

Return on Equity (ROE)	-54.75%
Return on Assets (ROA)	-32.50%
Return on Invested Capital (ROIC)	-36.34%
Return on Capital Employed (ROCE)	-41.41%
Weighted Average Cost of Capital (WACC)	11.68%
Revenue Per Employee	n/a
Profits Per Employee	-$1.48M
Employee Count	59
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.37% in the last 52 weeks. The beta is 1.39, so LXEO's price volatility has been higher than the market average.

Beta (5Y)	1.39
52-Week Price Change	+13.37%
50-Day Moving Average	5.27
200-Day Moving Average	7.14
Relative Strength Index (RSI)	46.81
Average Volume (20 Days)	945,792

Short Selling Information

The latest short interest is 14.09 million, so 17.94% of the outstanding shares have been sold short.

Short Interest	14.09M
Short Previous Month	13.78M
Short % of Shares Out	17.94%
Short % of Float	29.66%
Short Ratio (days to cover)	18.10

Income Statement

Revenue	n/a
Gross Profit	-62.33M
Operating Income	-97.79M
Pretax Income	-87.50M
Net Income	-87.50M
EBITDA	-97.18M
EBIT	-97.79M
Earnings Per Share (EPS)	-$1.33

Full Income Statement

Balance Sheet

The company has $193.04 million in cash and $7.37 million in debt, giving a net cash position of $185.68 million or $2.36 per share.

Cash & Cash Equivalents	193.04M
Total Debt	7.37M
Net Cash	185.68M
Net Cash Per Share	$2.36
Equity (Book Value)	231.50M
Book Value Per Share	3.12
Working Capital	186.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$97.99 million and capital expenditures -$432,000, giving a free cash flow of -$98.42 million.

Operating Cash Flow	-97.99M
Capital Expenditures	-432,000
Depreciation & Amortization	601,000
Net Borrowing	-495,000
Free Cash Flow	-98.42M
FCF Per Share	-$1.25

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LXEO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-98.55%
Shareholder Yield	-98.55%
Earnings Yield	-23.46%
FCF Yield	-26.39%

Analyst Forecast

The average price target for LXEO is $20.60, which is 333.68% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.60
Price Target Difference	333.68%
Analyst Consensus	Strong Buy
Analyst Count	10
Revenue Growth Forecast (3Y)	n/a
EPS Growth Forecast (3Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1